An Empirical Process for the Design of High-Throughput Screening Deck Filters

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Journal of Chemical Information and Modeling

• Publication date

  2006-04-05

• Fields of study

  Medicine, Chemistry, Computer Science

• Identifiers
  DOI 10.1021/ci050504mPMID 16711725
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Deriving knowledge through data mining high-throughput screening data.

  2004cited by this paper
• Assessment of the consistency of medicinal chemists in reviewing sets of compounds.

  2004cited by this paper
• Recent developments in the design of mechanism-based and alternate substrate inhibitors of serine proteases.

  2004cited by this paper
• Characteristic physical properties and structural fragments of marketed oral drugs.

  2004cited by this paper
• In Vitro Resistance Studies of Hepatitis C Virus Serine Protease Inhibitors, VX-950 and BILN 2061

  2004cited by this paper
• Systematic analysis of large screening sets in drug discovery.

  2004cited by this paper
• Drug-like Annotation and Duplicate Analysis of a 23-Supplier Chemical Database Totalling 2.7 Million Compounds

  2004cited by this paper
• Enrichment of Extremely Noisy High-Throughput Screening Data Using a Naïve Bayes Classifier

  2004cited by this paper
• The Effect of Room-Temperature Storage on the Stability of Compounds in DMSO

  2003cited by this paper
• A specific mechanism of nonspecific inhibition.

  2003cited by this paper
• Identification and prediction of promiscuous aggregating inhibitors among known drugs.

  2003cited by this paper
• The Effect of Freeze/Thaw Cycles on the Stability of Compounds in DMSO

  2003cited by this paper
• A guide to drug discovery: Designing screens: how to make your hits a hit

  2003cited by this paper
• Studies on Repository Compound Stability in DMSO under Various Conditions

  2003cited by this paper
• A comparison of physiochemical property profiles of development and marketed oral drugs.

  2003cited by this paper
• A common mechanism underlying promiscuous inhibitors from virtual and high-throughput screening.

  2002cited by this paper
• Development of a virtual screening method for identification of "frequent hitters" in compound libraries.

  2002cited by this paper
• Prediction of 'drug-likeness'.

  2002cited by this paper
• Do structurally similar molecules have similar biological activity?

  2002cited by this paper
• Molecular Complexity and Its Impact on the Probability of Finding Leads for Drug Discovery

  2001cited by this paper
• Privileged molecules for protein binding identified from NMR-based screening.

  2000cited by this paper
• Small, noncovalent serine protease inhibitors

  1999cited by this paper
• Strategic Pooling of Compounds for High-Throughput Screening

  1999cited by this paper
• Identification of Biological Activity Profiles Using Substructural Analysis and Genetic Algorithms

  1998cited by this paper
• The properties of known drugs. 1. Molecular frameworks.

  1996cited by this paper

• druglikeFilter 1.0: An AI powered filter for collectively measuring the drug-likeness of compounds

  2025cites this paper
• Multi-domain Distribution Learning for De Novo Drug Design

  2025cites this paper
• A Machine Learning Platform for Isoform-Specific Identification and Profiling of Human Carbonic Anhydrase Inhibitors

  2025cites this paper
• Tackling assay interference associated with small molecules

  2024cites this paper
• Discovery of TNG908: A Selective, Brain Penetrant, MTA-Cooperative PRMT5 Inhibitor That Is Synthetically Lethal with MTAP-Deleted Cancers.

  2024cites this paper
• Developing a Semi-Supervised Approach Using a PU-Learning-Based Data Augmentation Strategy for Multitarget Drug Discovery

  2024cites this paper
• ChemFH: an integrated tool for screening frequent false positives in chemical biology and drug discovery

  2024cites this paper
• DIY Virtual Chemical Libraries - Novel Starting Points for Drug Discovery

  2023cites this paper
• Deep learning-based design and screening of benzimidazole-pyrazine derivatives as adenosine A2B receptor antagonists

  2023cites this paper
• Jumping from Fragment to Drug via Smart Scaffolds

  2022cites this paper
• ADMET profiling and molecular docking of potential antimicrobial peptides previously isolated from African catfish, Clarias gariepinus

  2022cites this paper
• Assessing machine learning approaches for predicting failures of investigational drug candidates during clinical trials

  2022cites this paper
• Computational investigation to identify potent inhibitors of the GTPase-Kirsten RAt sarcoma virus (K-Ras) mutants G12C and G12D

  2021cites this paper
• Analysis of the uncharted, druglike property space by self-organizing maps

  2021cites this paper
• BonMOLière: Small-Sized Libraries of Readily Purchasable Compounds, Optimized to Produce Genuine Hits in Biological Screens across the Protein Space

  2021cites this paper
• Benchmarking the mechanisms of frequent hitters: limitation of PAINS alerts.

  2021cites this paper
• ADMETlab 2.0: an integrated online platform for accurate and comprehensive predictions of ADMET properties

  2021cites this paper
• Scopy: an integrated negative design python library for desirable HTS/VS database design

  2020cites this paper
• Analysis of Nuisance Substructures and Aggregators in a Comprehensive Database of Food Chemical Compounds.

  2020cites this paper
• Evolution of Novartis' Small Molecule Screening Deck Design.

  2020cites this paper
• Autonomous discovery in the chemical sciences part I: Progress

  2020cites this paper
• Towards reproducible computational drug discovery

  2020cites this paper
• The Application of Negative Design to Design More Desirable Virtual Screening Library.

  2020cites this paper
• Autonome Entdeckung in den chemischen Wissenschaften, Teil I: Fortschritt

  2020cites this paper
• SMARTS.plus – A Toolbox for Chemical Pattern Design

  2020cites this paper
• Comparing Molecular Patterns Using the Example of SMARTS: Applications and Filter Collection Analysis

  2019cites this paper
• Comparing Molecular Patterns Using the Example of SMARTS: Theory and Algorithms

  2019cites this paper
• 5-Arylidene(chromenyl-methylene)-thiazolidinediones: Potential New Agents against Mutant Oncoproteins K-Ras, N-Ras and B-Raf in Colorectal Cancer and Melanoma

  2019cites this paper
• Constrained Bayesian optimization for automatic chemical design using variational autoencoders

  2019cites this paper
• Applications of Deep-Learning in Exploiting Large-Scale and Heterogeneous Compound Data in Industrial Pharmaceutical Research

  2019cites this paper
• Hit Dexter 2.0: Machine-Learning Models for the Prediction of Frequent Hitters

  2019cites this paper
• Hit-to-Lead: Hit Validation and Assessment.

  2018cites this paper
• A big data approach with artificial neural network and molecular similarity for chemical data mining and endocrine disruption prediction

  2018cites this paper
• Computational Toxicology Methods in Chemical Library Design and High-Throughput Screening Hit Validation.

  2018cites this paper
• Nuisance Compounds, PAINS Filters, and Dark Chemical Matter in the GSK HTS Collection

  2018cites this paper
• Fragment‐Based Phenotypic Lead Discovery: Cell‐Based Assay to Target Leishmaniasis

  2018cites this paper
• Luciferase Advisor: High-Accuracy Model To Flag False Positive Hits in Luciferase HTS Assays

  2018cites this paper
• Design of the LifeArc Index Set and Retrospective Review of Its Performance: A Collection for Sharing

  2018cites this paper
• Seven Year Itch: Pan-Assay Interference Compounds (PAINS) in 2017—Utility and Limitations

  2017cites this paper
• Deep Learning Based Regression and Multiclass Models for Acute Oral Toxicity Prediction with Automatic Chemical Feature Extraction

  2017cites this paper
• Comment on The Ecstasy and Agony of Assay Interference Compounds

  2017cites this paper
• The ChEMBL database in 2017

  2016cites this paper
• Identification of Small-Molecule Frequent Hitters of Glutathione S-Transferase–Glutathione Interaction

  2016cites this paper
• Application of virtual screening to the discovery of novel nicotinamide phosphoribosyltransferase (NAMPT) inhibitors with potential for the treatment of cancer and axonopathies.

  2016cites this paper
• Prioritization of anti-malarial hits from nature: chemo-informatic profiling of natural products with in vitro antiplasmodial activities and currently registered anti-malarial drugs

  2016cites this paper
• Computational Techniques to Support Hit Triage

  2015cites this paper
• Assay Interference by Chemical Reactivity

  2015cites this paper
• Post-HTS case report and structural alert: Promiscuous 4-aroyl-1,5-disubstituted-3-hydroxy-2H-pyrrol-2-one actives verified by ALARM NMR.

  2015cites this paper
• A reliable computational workflow for the selection of optimal screening libraries

  2015cites this paper
• FAF-Drugs3: a web server for compound property calculation and chemical library design

  2015cites this paper
• - Library Design, Chemical Space, and Drug Likeness

  2015cites this paper
• The challenging world of in silico drug design: tools development and applications

  2014cites this paper
• Computational Prediction and Validation of an Expert's Evaluation of Chemical Probes

  2014cites this paper
• Identification of Small-Molecule Frequent Hitters from AlphaScreen High-Throughput Screens

  2014cites this paper
• Development of a Novel Screening Strategy Designed to Discover a New Class of HIV Drugs

  2014cites this paper
• Progress in computational toxicology.

  2014cites this paper
• Identification of Small Molecules That Selectively Inhibit Diacylglycerol Lipase–α Activity

  2014cites this paper
• Begin with the End in Mind

  2014cites this paper
• Quality Issues with Public Domain Chemogenomics Data

  2013cites this paper
• High-throughput approaches for the assessment of factors influencing bioavailability of small molecules in pre-clinical drug development

  2013cites this paper
• Antitubercular specific activity of ibuprofen and the other 2-arylpropanoic acids using the HT-SPOTi whole-cell phenotypic assay

  2013cites this paper
• Assay Considerations for Compound Library Screening

  2013cites this paper
• High-Throughput Identification of Promiscuous Inhibitors from Screening Libraries with the Use of a Thiol-Containing Fluorescent Probe

  2013cites this paper
• Broad Coverage of Commercially Available Lead-like Screening Space with Fewer than 350, 000 Compounds

  2013cites this paper
• Early phase drug discovery: cheminformatics and computational techniques in identifying lead series.

  2012cites this paper
• Rules for identifying potentially reactive or promiscuous compounds.

  2012cites this paper
• Screening for Safety‐Relevant Off‐Target Activities

  2012cites this paper
• Shaping a Screening File for Maximal Lead Discovery Efficiency and Effectiveness: Elimination of Molecular Redundancy

  2012cites this paper
• Applying Medicinal Chemistry Transformations and Multiparameter Optimization to Guide the Search for High-Quality Leads and Candidates

  2011cites this paper
• Preparing and Filtering Compound Databases for Virtual and Experimental Screening

  2011cites this paper
• HTS Promiscuity Analyses for Accelerating Decision Making

  2011cites this paper
• Rational methods for the selection of diverse screening compounds.

  2011cites this paper
• Pioneering Use of the Cloud for Development of Collaborative Drug Discovery (CDD) Database

  2011cites this paper
• Redox-active nuisance screening compounds and their classification

  2011cites this paper
• New substructure filters for removal of pan assay interference compounds (PAINS) from screening libraries and for their exclusion in bioassays.

  2010cites this paper
• Computational methods and software in computer-aided combinatorial library design

  2010cites this paper
• A Predictive Ligand-Based Bayesian Model for Human Drug-Induced Liver Injury

  2010cites this paper
• High Throughput Screening Approach to Lead Discovery

  2010cites this paper
• Meta-analysis of molecular property patterns and filtering of public datasets of antimalarial “hits” and drugs

  2010cites this paper
• In Silico ADME/Tox Predictions

  2010cites this paper
• Evolving molecules using multi-objective optimization: applying to ADME/Tox.

  2010cites this paper
• False positives in the early stages of drug discovery.

  2010cites this paper
• Quantitative analyses of aggregation, autofluorescence, and reactivity artifacts in a screen for inhibitors of a thiol protease.

  2010cites this paper
• Analysis and hit filtering of a very large library of compounds screened against Mycobacterium tuberculosis.

  2010cites this paper
• A Practical Method for Targeted Library Design Balancing Lead‐like Properties with Diversity

  2009cites this paper
• Free online resources enabling crowd-sourced drug discovery

  2009cites this paper
• Maximum Unbiased Validation (MUV) Data Sets for Virtual Screening Based on PubChem Bioactivity Data

  2009cites this paper
• High-Throughput Screening and Drug Discovery

  2008cites this paper
• Case study: impact of technology investment on lead discovery at Bristol-Myers Squibb, 1998-2006.

  2008cites this paper
• Which aspects of HTS are empirically correlated with downstream success?

  2008cites this paper
• FAF-Drugs2: Free ADME/tox filtering tool to assist drug discovery and chemical biology projects

  2008cites this paper
• Understanding False Positives in Reporter Gene Assays: in Silico Chemogenomics Approaches To Prioritize Cell-Based HTS Data

  2007cites this paper
• Lessons Learnt from Assembling Screening Libraries for Drug Discovery for Neglected Diseases

  2007cites this paper
• An Empirical Process for the Design of High-Throughput Screening Deck Filters.

  2006cites this paper
• How good is your screening library?

  2006cites this paper
• Knowledge-based chemoinformatic approaches to drug discovery.

  2006cites this paper
• Similarity Metrics and Descriptor Spaces – Which Combinations to Choose?

  2006cites this paper
• Streamlining lead discovery by aligning in silico and high-throughput screening.

  2006cites this paper
• Computational Toxicology Methods in Chemical Library Design and High-Throughput Screening Hit Validation.

  year unknowncites this paper
• The Future of Computational Models for Predicting Human Toxicities

  year unknowncites this paper